QT
MRVI icon

Quantbot Technologies’s Maravai LifeSciences MRVI Stock Holding History

Quantbot Technologies’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.06K Sell
1,436
-58,887
-98% -$200K ﹤0.01% 1585
2025
Q4 		$196K Buy
60,323
+29,449
+95% +$99.1K 0.01% 1243
2025
Q3 		$88.6K Buy
+30,874
New +$78.8K ﹤0.01% 1449
2024
Q4 		– Sell
-7,432
Closed -$61.8K – 1694
2024
Q3 		$61.8K Sell
7,432
-8,945
-55% -$77.3K ﹤0.01% 1254
2024
Q2 		$117K Buy
+16,377
New +$141K 0.01% 1094
2023
Q4 		– Sell
-65,219
Closed -$652K – 1841
2023
Q3 		$652K Buy
+65,219
New +$716K 0.04% 550
2023
Q1 		– Sell
-127,030
Closed -$1.82M – 1872
2022
Q4 		$1.82M Buy
+127,030
New +$2M 0.13% 237
2022
Q2 		– Sell
-69,305
Closed -$2.44M – 1968
2022
Q1 		$2.44M Buy
69,305
+43,444
+168% +$1.46M 0.21% 118
2021
Q4 		$1.08M Buy
25,861
+10,337
+67% +$419K 0.09% 332
2021
Q3 		$761K Sell
15,524
-53,136
-77% -$2.59M 0.06% 468
2021
Q2 		$2.87M Buy
68,660
+61,629
+877% +$2.39M 0.23% 116
2021
Q1 		$250K Buy
+7,031
New +$233K 0.02% 664

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quantbot Technologies's MRVI Position: Q1 2026 in Review

Quantbot Technologies reduced its Maravai LifeSciences (MRVI) stake by 98% in Q1 2026, selling an estimated $200K and leaving 1,436 shares worth $4.06K. The position accounts for ﹤0.01% of the portfolio, ranked #1585.

Quantbot Technologies first reported a position in MRVI in Q1 2021 and has held it in 12 quarters since. The position peaked at $2.87M in Q2 2021. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Quantbot Technologies held 1,436 shares of Maravai LifeSciences worth $4.06K as of Q1 2026.
  • Quantbot Technologies sold 58,887 Maravai LifeSciences shares in Q1 2026, an estimated $200K.
  • Maravai LifeSciences made up ﹤0.01% of Quantbot Technologies's portfolio in Q1 2026, its #1585 holding.
  • Quantbot Technologies first reported a position in Maravai LifeSciences in Q1 2021 and has held it in 12 quarters since.
  • Quantbot Technologies's Maravai LifeSciences position peaked at $2.87M in Q2 2021.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.